BackGongwin Biopharm Holdings , Ltd. Overview

Gongwin Biopharm Holdings , Ltd. Receivables

Track Gongwin Biopharm Holdings , Ltd.'s receivables ($20M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$19.94M
↓ 18.97% YoYΔ $-4.67M vs prior year quarter

Peer trimmed avg / median

Loading

Gongwin Biopharm Holdings , Ltd. Receivables History

Loading

Gongwin Biopharm Holdings , Ltd. vs. peers: Receivables Comparison

Loading

Gongwin Biopharm Holdings , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Gongwin Biopharm Holdings , Ltd. (6617.TWO) FAQ

Gongwin Biopharm Holdings , Ltd. (6617.TWO) currently reports a receivables of $20M as of June 2026. That compares with $25M in the prior-year period — down 19.0% year over year. Use the charts on this page to explore Gongwin Biopharm Holdings , Ltd.'s receivables history and peer comparisons.

Gongwin Biopharm Holdings , Ltd.'s receivables decreased from $25M to $20M — a 19.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gongwin Biopharm Holdings , Ltd. reported $20M in receivables as of June 2026. That compares with $25M in the prior-year period — down 19.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gongwin Biopharm Holdings , Ltd., and consider following 6617.TWO for alerts when major investors trade the stock.